Usefulness of age-specific reference range of prostate-specific antigen for japanese men older than 60 years in mass screening for prostate cancer
- 1 August 2000
- Vol. 56 (2), 278-282
- https://doi.org/10.1016/s0090-4295(00)00613-0
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- The Present Status, Problems, and Future of Mass Screening for Prostate Cancer in Gunma Prefecture: The Report of Mass Screening for Prostate Cancer Study Meeting in 1998.The Kitakanto Medical Journal, 1999
- Most prostate cancers missed by raising the upper limit of normal prostate-specific antigen for men in their sixties are clinically significantUrology, 1998
- Age- and race-specific reference ranges for prostate-specific antigen from a large community-based studyUrology, 1996
- Age-specific prostate-specific antigen: A reassessmentThe Prostate, 1996
- Derivation and application of upper limits for prostate specific antigen in men aged 50-74 years with no clinical evidence of prostatic carcinomaBritish Journal of Urology, 1995
- Normal range prostate-specific antigen versus age-specific prostate-specific antigen in screening prostate adenocarcinomaUrology, 1995
- Age-specific reference ranges for serum prostate-specific antigenUrology, 1995
- Serum prostate‐specific antigen in a community‐based population of healthy Japanese men: lower values than for similarly aged white menBritish Journal of Urology, 1995
- Selection of Optimal Prostate Specific Antigen Cutoffs for Early Detection of Prostate Cancer: Receiver Operating Characteristic CurvesJournal of Urology, 1994
- Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference rangesJAMA, 1993